Advertisement

The Latest

The University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences has received a $300,000 grant from the Centene Foundation and Health Net to expand services at its USC Pharmacy and Wellness Center in South Los Angeles. The funding…

The American Hospital Association has filed a friend-of-the-court brief supporting HHS’ motion to dismiss AbbVie’s lawsuit challenging the agency’s longstanding definition of “patient” under the 340B Drug Pricing Program.  The brief, filed July 14, argues AbbVie is attempting to bypass…

CVS Health wants to position itself as the primary data host for the Trump administration’s push on healthcare interoperability, CEO David Joyner told Politico in a July 16 interview. Mr. Joyner, who oversees a company spanning pharmacies, primary care clinics…

Drug costs are emerging as one of hospitals’ fastest-growing expense categories, outpacing labor and other nonlabor costs as organizations continue to navigate a challenging financial environment, according to Kaufman Hall’s latest “National Hospital Flash Report.” Nationally, drug expense per adjusted…

A cyberattack on New Jersey law firm Greenbaum Rowe Smith & Davis has exposed data on 12,801 patients across three health systems in the state. Greenbaum discovered unauthorized access to its systems through a compromised user account in November 2025…

The FDA has approved Merck’s Lipfendra (enlicitide), a once-daily oral therapy to reduce low-density lipoprotein cholesterol in adults with high cholesterol or heterozygous familial hypercholesterolemia. The approval was supported by two randomized, double-blind, placebo-controlled trials involving 3,207 adults already taking…

Advertisement